Publisher: Allergic Living

These measurements indicate that the epinephrine is being absorbed and will work to treat real-world anaphylaxis, says Dr. Jay Lieberman, an allergist-immunologist at University of Tennessee Health Science Center. Called “pharmacokinetic” and “pharmacodynamic” data, the research is also what the FDA scrutinizes in approval consideration.

Dr. Jay Lieberman, an allergist-immunologist at University of Tennessee Health Science Center, calls the new treatment option exciting for patients, families and allergists.

Dr. Jay Lieberman, an allergist-immunologist at University of Tennessee Health Science Center, said studies show neffy should work comparably to auto-injectors during allergic reactions.